Xiangyi Zheng

First Affiliated Hospital Zhejiang University

Papers

Total Citations

H-Index

About

Dr. Xiangyi Zheng is a prominent urological surgeon and researcher whose work centers on improving outcomes for prostate cancer patients, with a particular focus on surgical precision and postoperative management. Based at a high-volume center in Southeast China, Dr. Zheng has made significant contributions to understanding the clinical factors that influence treatment success. In their highly cited 2024 study, "Analysis of risk factors for persistent PSA after radical prostatectomy," Dr. Zheng analyzed data from a large patient cohort to identify key predictors of residual prostate-specific antigen (PSA) following surgery—a critical marker for cancer recurrence. This work, which has already garnered 4 citations shortly after publication, provides actionable insights for surgeons aiming to optimize radical prostatectomy outcomes and reduce the need for additional therapies. Dr. Zheng’s research bridges the gap between surgical technique and long-term oncological control, offering valuable guidance for clinicians managing localized prostate cancer. Their dedication to evidence-based practice and large-scale data analysis continues to shape urological care in Southeast China and beyond.